+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Insulin"

Pediatric Growth Hormone Deficiency Market Report 2026 - Product Thumbnail Image

Pediatric Growth Hormone Deficiency Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Insulin Patch Pumps Market Report 2026 - Product Thumbnail Image

Insulin Patch Pumps Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Diabetes Treatment Devices Market Report 2026 - Product Thumbnail Image

Diabetes Treatment Devices Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
Insulin Delivery Devices Market Report 2026 - Product Thumbnail Image

Insulin Delivery Devices Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Smart Insulin Pens Market Report 2026 - Product Thumbnail Image

Smart Insulin Pens Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Insulin Pens, Syringes, Pumps and Injectors Market Report 2026 - Product Thumbnail Image

Insulin Pens, Syringes, Pumps and Injectors Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Diabetic Peripheral Neuropathy- Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Peripheral Neuropathy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
From
From
From
Thyroid Eye Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Thyroid Eye Disease - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
From
Diabetic Nephropathy- Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Nephropathy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
NLRP3 Protein Inhibitors- Pipeline Insight, 2025 - Product Thumbnail Image

NLRP3 Protein Inhibitors- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Diabetes - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Hypertriglyceridemia - Pipeline Insight, 2025 - Product Thumbnail Image

Hypertriglyceridemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump. The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more